Saturday 17 October 2026
Export NVST’s income statement to Excel — free account
Envista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.
22.90
0.60
−2.55%
Follow NVST
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 4 | 8 | 4 | 3 | 3 | 7 |
P/E ratio |
5.52 | 5.52 | 5.52 | 18.44 | 168.65 | 21.25 | 22.79 | 0.00 | 0.00 | 77.54 |
Altman Z-Score |
— | — | — | 1.50 | 1.33 | 2.48 | 2.12 | 1.70 | 0.73 | 1.59 |
P/S ratio |
0.00 | 0.00 | 0.00 | 1.77 | 2.79 | 2.90 | 2.15 | 1.57 | 1.32 | 1.34 |
P/FCF ratio |
8.96 | 8.96 | 8.96 | 12.56 | 22.29 | 22.81 | 50.15 | 17.99 | 10.97 | 15.80 |
Altman Z″-Score (non-manufacturers) |
— | — | — | 2.04 | 1.25 | 2.86 | 2.73 | 3.10 | 0.79 | 2.63 |
P/Operating CF |
29.37 | 29.37 | 29.37 | 21.59 | 27.84 | 53.41 | 50.15 | 39.43 | 25.09 | 33.77 |
Beneish M-Score |
— | — | — | (3.35) | (3.03) | (2.40) | (2.24) | (2.74) | (3.98) | (2.50) |
P/B ratio |
0.74 | 0.74 | 0.74 | 1.14 | 1.45 | 1.79 | 1.32 | 0.96 | 1.13 | 1.17 |
Price to Tangible BV |
0.74 | 0.74 | 0.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 144.42 | 30.17 |
EV/Sales |
0.00 | 0.00 | 0.00 | 2.25 | 3.26 | 2.99 | 2.45 | 1.79 | 1.45 | 1.47 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 12.76 | 28.59 | 15.59 | 12.99 | 23.13 | 0.00 | 10.78 |
EV/Operating CF |
6.97 | 6.97 | 6.97 | 12.96 | 22.15 | 20.76 | 34.52 | 16.67 | 10.84 | 14.51 |
EV/FCF |
8.96 | 8.96 | 8.96 | 16.03 | 26.04 | 23.57 | 57.17 | 20.55 | 12.04 | 17.32 |
Quick Ratio |
— | 0.74 | 0.72 | 0.92 | 0.71 | 1.16 | 0.81 | 1.73 | 1.63 | 1.93 |
Current Ratio |
— | 1.27 | 1.23 | 1.41 | 0.94 | 1.52 | 1.15 | 2.23 | 2.04 | 2.38 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 2.76 | 4.12 | 0.50 | 1.59 | 2.89 | (0.37) | 0.64 |
Debt/Assets |
— | 0.00% | 0.00% | 21.51% | 26.10% | 20.01% | 20.96% | 22.91% | 26.06% | 25.50% |
Debt/Equity |
— | 0.00 | 0.00 | 0.37 | 0.48 | 0.32 | 0.33 | 0.36 | 0.48 | 0.47 |
Asset Turnover |
0.00 | 0.48 | 0.97 | 0.38 | 0.30 | 0.37 | 0.39 | 0.39 | 0.42 | 0.49 |
Operating CF/Net income |
1.53 | 1.19 | 1.73 | 1.83 | 8.53 | 1.06 | 0.75 | (2.75) | (0.30) | 5.87 |
Capex/Depreciation |
0.00 | (0.40) | (0.56) | (0.45) | (0.24) | (0.25) | (0.44) | (0.31) | (0.21) | (0.29) |
Interest Coverage |
— | — | — | 67.34 | 0.70 | 5.66 | 8.31 | 0.50 | (22.37) | 5.90 |
| 0.00% | 6.14% | 4.70% | 5.20% | 0.92% | 8.75% | 5.88% | (2.39%) | (31.47%) | 1.56% | |
| 0.00% | 5.09% | 7.90% | 3.63% | 0.51% | 5.06% | 3.69% | (1.52%) | (18.71%) | 0.85% | |
ROIC |
— | 0.00% | 3.86% | 3.16% | 0.59% | 4.45% | 4.01% | 0.41% | (19.90%) | 4.04% |
Return on Tangible Assets |
0.00% | 75.65% | 56.63% | 37.32% | 18.45% | 38.19% | 50.49% | (7.87%) | (94.27%) | 3.20% |
Average Days of Receivables |
0.00 | 60.12 | 59.00 | 70.87 | 57.08 | 48.29 | 55.91 | 57.95 | 52.77 | 57.66 |
Research and Development Expense of Revenue |
5.13% | 6.13% | 6.05% | 5.83% | 4.49% | 4.01% | 3.90% | 3.65% | 3.95% | 4.19% |
Selling, General and Administrative Expense of Revenue |
37.09% | 37.79% | 39.78% | 42.91% | 47.93% | 40.65% | 41.08% | 41.18% | 46.12% | 42.53% |
Intangible Assets out of Total Assets |
— | 0.00 | 0.81 | 0.75 | 0.63 | 0.64 | 0.70 | 0.64 | 0.54 | 0.53 |
Share Based Compensation of Revenue |
0.00% | 0.44% | 0.47% | 0.81% | 1.17% | 1.12% | 1.19% | 1.20% | 1.41% | 1.38% |
Graham Net Nets |
0.22 | 0.22 | 0.22 | (0.40) | (0.29) | (0.09) | (0.17) | (0.17) | (0.19) | (0.15) |
Graham Number |
0.00 | 0.00 | 0.00 | 30.67 | 10.24 | 34.65 | 29.42 | 0.00 | 0.00 | 10.79 |
Earnings Yield |
18.10% | 18.10% | 18.10% | 5.42% | 0.59% | 4.70% | 4.39% | (2.28%) | (33.64%) | 1.29% |
Free Cash Flow Yield |
11.16% | 11.16% | 11.16% | 7.96% | 4.49% | 4.38% | 1.99% | 5.56% | 9.12% | 6.33% |
Revenue per Share |
17.52 | 21.98 | 22.24 | 16.78 | 12.09 | 15.56 | 15.77 | 15.38 | 14.58 | 16.19 |
Operating CF per Share |
2.62 | 2.81 | 3.13 | 2.92 | 1.78 | 2.24 | 1.12 | 1.65 | 1.95 | 1.64 |
Capex per Share |
0.00 | (0.38) | (0.56) | (0.56) | (0.27) | (0.27) | (0.44) | (0.31) | (0.20) | (0.27) |
Free Cash Flow per Share |
2.62 | 2.43 | 2.56 | 2.36 | 1.51 | 1.98 | 0.68 | 1.34 | 1.76 | 1.37 |
Cash per Share |
0.00 | 0.00 | 0.00 | 1.55 | 5.57 | 6.66 | 3.73 | 5.63 | 6.21 | 7.21 |
Shareholders Equity per Share |
0.00 | 0.00 | 37.74 | 26.01 | 23.31 | 25.17 | 25.83 | 25.01 | 17.04 | 18.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 37.74 | 26.01 | 23.31 | 25.17 | 25.83 | 25.01 | 17.04 | 18.49 |
Free Cash Flow |
417.00 | 310.30 | 327.90 | 321.30 | 241.50 | 318.50 | 110.30 | 223.60 | 302.80 | 230.90 |
Working Capital |
— | 167.00 | 145.80 | 292.70 | (94.10) | 627.60 | 187.90 | 962.90 | 909.60 | 1,174.00 |
Capital Expenditures |
(49.10) | (48.80) | (72.20) | (76.20) | (42.40) | (43.10) | (72.40) | (52.10) | (33.70) | (44.80) |
Net Current Asset Value |
— | 795.00 | (228.40) | (1,613.60) | (1,564.40) | (680.40) | (955.50) | (687.50) | (627.40) | (546.10) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 21.85 | 144.57 | 24.51 | 19.76 | 145.89 | 0.00 | 18.51 |
Capex to Sales |
0.00 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 17.13 | 123.75 | 23.72 | 17.33 | 127.69 | 0.00 | 16.88 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.53 | 0.50 | 0.58 | 0.64 | 0.66 | 0.57 | 0.54 | 0.58 | 0.52 |
Cash ROIC |
0.00% | 0.00% | 6.79% | 6.33% | 3.77% | 4.94% | 1.78% | 3.37% | 5.61% | 4.00% |
Accounts Receivable Turnover |
0.00 | 6.09 | 6.16 | 5.06 | 5.18 | 7.92 | 7.08 | 6.41 | 6.52 | 6.86 |
Accounts Payable Turnover |
9.88 | 10.03 | 5.66 | 4.40 | 4.26 | 5.58 | 5.29 | 5.52 | 6.43 | 6.73 |
Inventory Turnover |
8.78 | 8.91 | 4.48 | 3.36 | 3.54 | 4.51 | 3.88 | 4.02 | 4.55 | 4.66 |
Average Days of Payables |
4.76 | 68.11 | 63.85 | 81.15 | 84.54 | 62.65 | 76.15 | 58.19 | 56.01 | 56.73 |
Days of Inventory on Hand |
(2.77) | 84.68 | 81.86 | 108.42 | 90.18 | 88.96 | 100.33 | 83.89 | 77.30 | 85.30 |
Average Receivables |
— | 461.50 | 461.40 | 451.70 | 372.65 | 316.80 | 362.70 | 400.50 | 385.25 | 396.30 |
Average Payables |
118.65 | 118.65 | 219.70 | 212.70 | 205.25 | 194.15 | 207.05 | 203.90 | 177.05 | 183.10 |
Average Inventory |
133.55 | 133.55 | 277.35 | 278.30 | 246.95 | 239.90 | 282.30 | 279.80 | 249.90 | 264.55 |
Average Assets |
— | 5,917.50 | 2,920.80 | 5,999.95 | 6,517.15 | 6,725.10 | 6,580.60 | 6,596.05 | 5,977.80 | 5,514.75 |
Average Common Equity |
— | 4,907.00 | 4,908.70 | 4,184.60 | 3,631.90 | 3,889.50 | 4,132.45 | 4,190.40 | 3,554.35 | 3,020.55 |
Columns are period end dates